Curis Stock Is On A Wild Ride — What Spooked Investors After A 65% Surge

Curis Stock Is On A Wild Ride — What Spooked Investors After A 65% Surge

Curis is taking investors on a wild ride. After rocketing on a promising blood-cancer drug on Wednesday, CRIS stock plummeted Thursday on dose-limiting toxicities facing its drug.